NM_005104.4:c.-1765G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005104.4(BRD2):c.-1765G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.118 in 152,992 control chromosomes in the GnomAD database, including 1,303 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.12 ( 1297 hom., cov: 33)
Exomes 𝑓: 0.12 ( 6 hom. )
Consequence
BRD2
NM_005104.4 5_prime_UTR
NM_005104.4 5_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.109
Publications
19 publications found
Genes affected
BRD2 (HGNC:1103): (bromodomain containing 2) This gene encodes a transcriptional regulator that belongs to the BET (bromodomains and extra terminal domain) family of proteins. This protein associates with transcription complexes and with acetylated chromatin during mitosis, and it selectively binds to the acetylated lysine-12 residue of histone H4 via its two bromodomains. The gene maps to the major histocompatability complex (MHC) class II region on chromosome 6p21.3, but sequence comparison suggests that the protein is not involved in the immune response. This gene has been implicated in juvenile myoclonic epilepsy, a common form of epilepsy that becomes apparent in adolescence. Multiple alternatively spliced variants have been described for this gene. [provided by RefSeq, Dec 2010]
HLA-DMA (HGNC:4934): (major histocompatibility complex, class II, DM alpha) HLA-DMA belongs to the HLA class II alpha chain paralogues. This class II molecule is a heterodimer consisting of an alpha (DMA) and a beta chain (DMB), both anchored in the membrane. It is located in intracellular vesicles. DM plays a central role in the peptide loading of MHC class II molecules by helping to release the CLIP molecule from the peptide binding site. Class II molecules are expressed in antigen presenting cells (APC: B lymphocytes, dendritic cells, macrophages). The alpha chain is approximately 33-35 kDa and its gene contains 5 exons. Exon one encodes the leader peptide, exons 2 and 3 encode the two extracellular domains, exon 4 encodes the transmembrane domain and the cytoplasmic tail. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.242 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BRD2 | ENST00000374825.9 | c.-1765G>A | 5_prime_UTR_variant | Exon 1 of 13 | 1 | NM_005104.4 | ENSP00000363958.4 | |||
| HLA-DMA | ENST00000422832.1 | c.-12+406C>T | intron_variant | Intron 1 of 2 | 6 | ENSP00000403122.1 | ||||
| HLA-DMA | ENST00000464392.1 | n.-152C>T | upstream_gene_variant | 6 |
Frequencies
GnomAD3 genomes AF: 0.118 AC: 17895AN: 152096Hom.: 1289 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
17895
AN:
152096
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.125 AC: 97AN: 778Hom.: 6 Cov.: 0 AF XY: 0.112 AC XY: 67AN XY: 598 show subpopulations
GnomAD4 exome
AF:
AC:
97
AN:
778
Hom.:
Cov.:
0
AF XY:
AC XY:
67
AN XY:
598
show subpopulations
African (AFR)
AF:
AC:
0
AN:
10
American (AMR)
AF:
AC:
1
AN:
12
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
6
East Asian (EAS)
AF:
AC:
3
AN:
16
South Asian (SAS)
AF:
AC:
15
AN:
80
European-Finnish (FIN)
AF:
AC:
2
AN:
30
Middle Eastern (MID)
AF:
AC:
1
AN:
8
European-Non Finnish (NFE)
AF:
AC:
65
AN:
580
Other (OTH)
AF:
AC:
10
AN:
36
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.118 AC: 17900AN: 152214Hom.: 1297 Cov.: 33 AF XY: 0.121 AC XY: 8988AN XY: 74426 show subpopulations
GnomAD4 genome
AF:
AC:
17900
AN:
152214
Hom.:
Cov.:
33
AF XY:
AC XY:
8988
AN XY:
74426
show subpopulations
African (AFR)
AF:
AC:
2642
AN:
41548
American (AMR)
AF:
AC:
2834
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
571
AN:
3470
East Asian (EAS)
AF:
AC:
1308
AN:
5160
South Asian (SAS)
AF:
AC:
1086
AN:
4830
European-Finnish (FIN)
AF:
AC:
1073
AN:
10618
Middle Eastern (MID)
AF:
AC:
38
AN:
294
European-Non Finnish (NFE)
AF:
AC:
7891
AN:
67972
Other (OTH)
AF:
AC:
284
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
837
1675
2512
3350
4187
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
861
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.